NCT06997796View on ClinicalTrials.gov

Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Epistaxis Nosebleed
Interventions
DRUG

Tranexamic Acid

Tranexamic acid powder intranasally

Trial Locations (1)

K9J 7C6

RECRUITING

Peterborough Regional Health Centre, Peterborough

All Listed Sponsors
collaborator

University of Ottawa

OTHER

lead

Dr. Anne Conlin

OTHER

NCT06997796 - Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid | Biotech Hunter | Biotech Hunter